BIMET Study: Evolution of Metabolic and Cardiovascular Risks Factors in Patients With Bipolar Disorder
Clinical trial NCT00584961 · COMPLETED
Trial details
- NCT number
- NCT00584961
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2007-05-01
- Primary completion
- 2009-02-01
- Enrollment
- 553
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.